超声心动图评价肝硬化心肌病的研究进展评述  

Echocardiography in the evaluation of cirrhotic cardiomyopathy

作　　者：张俊清 周秘[2] 尹立雪[1,3] ZHANG Junqing;ZHOU Mi;YIN Lixue(Clinical Medicine Academy,Southwest Medical University,Luzhou 646000,Sichuan,China;Chengdu Wenjiang District People's Hospital,Chengdu 611130,China;Cardiovascular Ultrasound and Non-invasive Cardiology Department,Sichuan Academy of Medical Sciences,Sichuan Provincial People's Hospital,Key Laboratory of Ultrasound in Cardiac Electrophysiology and Bio-mechanics of Sichuan Province,Chengdu 610072,China)

机构地区：[1]西南医科大学临床医学院,四川泸州646000 [2]成都市温江区人民医院,四川成都611130 [3]四川省医学科学院·四川省人民医院心血管超声及心功能科,超声心脏电生理学与生物力学四川省重点实验室,四川成都610072

出　　处：《西部医学》2024年第7期937-942,共6页Medical Journal of West China

基　　金：国家重点研发计划项目(2020YFC2008000)。

摘　　要：肝硬化心肌病(CCM)是肝硬化患者的常见并发症,主要表现为机体在应激状态的心肌收缩功能不全和/或舒张功能降低伴电生理异常。超声心动图作为一种临床心脏影像学技术具有可及性强和系统性一站式心血管解剖结构和功能评估等诸多优势,已广泛应用于CCM的诊断。CCM发病机制复杂、血流动力学多变,超声心动图单一技术和/或参数很难全面和准确的监测CCM相关的隐匿性心血管结构和功能异常。本文就超声心动图对CCM心脏结构、功能评估的研究进展作一述评,以期能够推动这项技术的广泛临床应用。Cirrhosis cardiomyopathy(CCM)was a common complication observed among patients with cirrhosis,which is characterized by cardiac contractile insufficiency and/or diastolic dysfunction under a stressful condition that is accompanied by electrophysiological abnormalities.Echocardiography,as a clinical cardiac imaging technique displayed with numerous advantages,including robust accessibility and the systematic assessment of cardiovascular anatomical structure and function in a one-stop manner.Consequently,it has been extensively used in CCM diagnosis.The pathogenesis and hemodynamics of CCM is intricate.It's challenging to comprehensively and precisely monitoring the subclinical cardiovascular structural and functional abnormalities related to CCM by a single echocardiographic technique or parameter.This article aims to summarize the research advancements in echocardiography in evaluating cardiac structure and function in CCM,facilitating a widely clinical utilization of this technology.

关 键 词：超声心动图 肝硬化心肌病 左心室收缩功能 斑点追踪技术 

分 类 号：R540.45[医药卫生—心血管疾病]